Explore

Trendline Trendline
Silexion Therapeutics Initiates GMP Manufacturing for Pancreatic Cancer Drug SIL204

Silexion Therapeutics Initiates GMP Manufacturing for Pancreatic Cancer Drug SIL204

Silexion Therapeutics Initiates GMP Manufacturing for Pancreatic Cancer Drug SIL204
Trendline Trendline
Incyte to Present Key Hematology and Oncology Data at EHA 2026 Congress

Incyte to Present Key Hematology and Oncology Data at EHA 2026 Congress

Incyte to Present Key Hematology and Oncology Data at EHA 2026 Congress
Trendline Trendline
Enterprise Therapeutics Achieves Key Milestone in Cystic Fibrosis Treatment with ETD001

Enterprise Therapeutics Achieves Key Milestone in Cystic Fibrosis Treatment with ETD001

Enterprise Therapeutics Achieves Key Milestone in Cystic Fibrosis Treatment with ETD001
Trendline Trendline
Dual-Ligase Strategy Enhances Targeted Protein Degradation in Cancer Therapy

Dual-Ligase Strategy Enhances Targeted Protein Degradation in Cancer Therapy

Dual-Ligase Strategy Enhances Targeted Protein Degradation in Cancer Therapy
Trendline Trendline
Anixa Biosciences Reports Positive Survival Data from Phase 1 Trial of Lira-cel Ovarian Cancer Therapy

Anixa Biosciences Reports Positive Survival Data from Phase 1 Trial of Lira-cel Ovarian Cancer Therapy

Anixa Biosciences Reports Positive Survival Data from Phase 1 Trial of Lira-cel Ovarian Cancer Therapy
Trendline Trendline
Anixa Biosciences Reports Positive Survival Data in Ovarian Cancer Trial

Anixa Biosciences Reports Positive Survival Data in Ovarian Cancer Trial

Anixa Biosciences Reports Positive Survival Data in Ovarian Cancer Trial
Trendline Trendline
Anixa Biosciences Reports Positive Survival Data in Ovarian Cancer CAR-T Therapy Trial

Anixa Biosciences Reports Positive Survival Data in Ovarian Cancer CAR-T Therapy Trial

Anixa Biosciences Reports Positive Survival Data in Ovarian Cancer CAR-T Therapy Trial
Trendline Trendline
Incyte to Present Over 20 Abstracts at European Hematology Association 2026 Congress

Incyte to Present Over 20 Abstracts at European Hematology Association 2026 Congress

Incyte to Present Over 20 Abstracts at European Hematology Association 2026 Congress
Trendline Trendline
Anixa Biosciences Announces Positive Survival Data from Phase 1 Ovarian Cancer CAR-T Therapy Trial

Anixa Biosciences Announces Positive Survival Data from Phase 1 Ovarian Cancer CAR-T Therapy Trial

Anixa Biosciences Announces Positive Survival Data from Phase 1 Ovarian Cancer CAR-T Therapy Trial
Trendline Trendline
Ankyra Therapeutics Showcases Anchored Immunotherapy at PEGS Boston 2026

Ankyra Therapeutics Showcases Anchored Immunotherapy at PEGS Boston 2026

Ankyra Therapeutics Showcases Anchored Immunotherapy at PEGS Boston 2026
Trendline Trendline
BeOne Medicines Honored as 'Outstanding Global Oncology Company' for Advancements in Cancer Therapies

BeOne Medicines Honored as 'Outstanding Global Oncology Company' for Advancements in Cancer Therapies

BeOne Medicines Honored as 'Outstanding Global Oncology Company' for Advancements in Cancer Therapies
Trendline Trendline
Inhibrx to Present Interim Results of INBRX-106 Study in Head and Neck Cancer

Inhibrx to Present Interim Results of INBRX-106 Study in Head and Neck Cancer

Inhibrx to Present Interim Results of INBRX-106 Study in Head and Neck Cancer